Exane Derivatives’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$3.23K Hold
58
﹤0.01% 408
2022
Q1
$3.22K Hold
58
﹤0.01% 721
2021
Q4
$3.25K Hold
58
﹤0.01% 630
2021
Q3
$2.78K Hold
58
﹤0.01% 760
2021
Q2
$2.51K Hold
58
﹤0.01% 787
2021
Q1
$1.96K Hold
58
﹤0.01% 660
2020
Q4
$2.03K Hold
58
﹤0.01% 610
2020
Q3
$2.01K Hold
58
﹤0.01% 538
2020
Q2
$1.9K Hold
58
﹤0.01% 486
2020
Q1
$1.75K Hold
58
﹤0.01% 484
2019
Q4
$1.81K Hold
58
﹤0.01% 479
2019
Q3
$1.5K Hold
58
﹤0.01% 483
2019
Q2
$1.48K Hold
58
﹤0.01% 507
2019
Q1
$1.52K Hold
58
﹤0.01% 447
2018
Q4
$1.34K Hold
58
﹤0.01% 516
2018
Q3
$1.37K Hold
58
﹤0.01% 480
2018
Q2
$1.34K Hold
58
﹤0.01% 476
2018
Q1
$1.43K Sell
58
-104
-64% -$2.56K ﹤0.01% 438
2017
Q4
$4.35K Sell
162
-490
-75% -$13.1K ﹤0.01% 387
2017
Q3
$15.7K Sell
652
-182
-22% -$4.38K ﹤0.01% 330
2017
Q2
$17.9K Hold
834
﹤0.01% 331
2017
Q1
$14.3K Sell
834
-1,066
-56% -$18.3K ﹤0.01% 313
2016
Q4
$34.1K Hold
1,900
0.01% 290
2016
Q3
$39.5K Sell
1,900
-1,150
-38% -$23.9K 0.01% 287
2016
Q2
$82K Sell
3,050
-62
-2% -$1.67K 0.01% 250
2016
Q1
$84.3K Buy
3,112
+314
+11% +$8.51K 0.01% 225
2015
Q4
$81.2K Buy
2,798
+1,348
+93% +$39.1K 0.01% 202
2015
Q3
$39.3K Buy
1,450
+1,248
+618% +$33.8K 0.01% 248
2015
Q2
$5.53K Sell
202
-3,492
-95% -$95.6K ﹤0.01% 345
2015
Q1
$98.6K Buy
+3,694
New +$98.6K 0.01% 237